ELISA – News and Features

In a first-of-its-kind study, EMBL researchers have shown how DNA methylation across the genome contributes to the precise regulation of gene expression

Diagnostic testing is key in many areas including healthcare and preventative medicine, food safety and environmental monitoring. In this article, we will consider what lateral flow tests (LFTs) are, how they work and their applications.

This article will review the latest applications of mass spectrometry-based techniques across the stages of biopharmaceutical development and testing.

To learn more about T-cell testing, the types of diseases it can help to diagnose and its value in clinical trials, we spoke to Phill Keefe, chief executive officer of PerkinElmer’s Oxford Immunotec division.

Researchers with the SFU Nanodevice Fabrication Group are developing a new biosensor that can be used to screen for Alzheimer’s disease and other diseases.

A study conducted at the University of Helsinki, Finland set out to determine how 13 dog breeds performed in various cognitive tests. With a sample size of over 1,000 dogs, the researchers found several breed differences in traits such as social cognition, problem-solving ability and inhibitory control.

In this interview, CEO of Arrayjet Dr. Iain McWilliam discusses advancements in modern microarray technology and the benefits that these tools can provide for high-throughput screening.

Scientists have developed an electrochemical immunosensor that rapidly detects antibodies against SARS-CoV-2.

Technology Networks spoke with Arvind Kothandaraman to find out about the technologies underpinning syndromic testing, recent advances in the field and its possible role in pandemic prevention.

This article will highlight the properties of an attractive drug target, outline the approaches used to identify targets and discuss the key steps involved in target validation.